
OBIO EPS Estimates
Orchestra BioMed Holdings, Inc.
$7.26
+$0.14(+1.97%)
62
Overall
60
Value
100
Tech
26
Quality
Market Cap
$571.40M
Volume
220.90K
52W Range
$3.46 - $7.37
Target Price
$12.50
OBIO EPS estimates: the consensus estimate for Orchestra BioMed Holdings, Inc.'s current fiscal year is -$1.46 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
OBIO EPS Estimates
- EPS estimate, current quarter
- $-0.38
- EPS estimate, next quarter
- $-0.37
- EPS estimate, current year
- $-1.46
- EPS estimate, next year
- $-1.44
- EPS growth, 3-year
- -86.91%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.11 |
| 2024 | $-1.66 |
| 2023 | $-1.48 |
| 2022 | $-0.17 |
| 2021 | $-0.02 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OBIO | $7.26 | +2.0% | 220.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Orchestra BioMed Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW